《大行报告》大和料国寿(02628.HK)下半年VNB增长领先同业 目标价上调至29.5元
大和发表报告指,中国人寿(02628.HK)为其内险企业中首选,料其下半年新业务价值(VNB)增长将领先同业,主要由於其新业务利润率较高。下半年虽首年保费增长放缓,惟新业务利润率续升。随着国寿现有足够财力向经纪提供激励以加大销售健保产品,产品组合亦有改善空间,致利润率可进一步提升。
该行亦预期国寿於明年「开门红」产品销售有先行者优势,上调明年新业务价值增长预测,自12%上调至14%,目标价相应自29元上调至29.5元,重申「买入」评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.